Hello! PhD Candidate in Bioengineering @UW, Cal bear, musician, pyro, Dnd nerd. Interested in stem cells, heart cells, and mechanotransduction
Seattle, WA
Joined May 2010
- Tweets115
- Following301
- Followers187
- Likes521
Happy to have written this commentary on the excellent study by the Kehat lab!
Abigail Nagle, Michael Regnier, and Jennifer Davis @UWMedicine highlight a recent study by Haddad et al. (buff.ly/3XTJd6x) :
Keeping it fresh: ribosomal protein SA sustains sarcomeric function via localized translation: buff.ly/3xIEzgO
Excited to have had a small contribution to this amazing and rigorous study in @CircAHA, entirely led by my incredible labmate @lrjbailey in @JD98119 lab! To learn more about how MBNL1 regulates mature vs developmental cell states during cardiac regeneration, check it out 👇
#OriginalResearch: Towards native heart regeneration: MBNL1 is an essential regulator of cardiomyocyte differentiation states @abbynagle @mjmaccoss #AHAJournals ahajournals.org/doi/10.1161/…
Abby Nagle retweeted
Over 7 years in the making, our scientists just debuted a new way to measure cell organization. Out today in @Nature, our cell science team outlines a framework for measuring cell-to-cell variability, including intracellular organization. nature.com/articles/s41586-0…
Abby Nagle retweeted
Call for companies! Come join us at our Fall mixer on October 26th! Attending a BioEngage mixer is a great opportunity to connect with talented students of all academic levels. Previous mixers have attracted over 150 students. Contact [email protected] for more information!
Abby Nagle retweeted
BREAKING: White House issues new policy that will require, by 2026, all federally-funded research results to be freely available to public without delay, ending longstanding ability of journals to paywall results for up to 1 year. Coverage coming on @ScienceInsider.
Abby Nagle retweeted
BioEngage is looking forward to hosting 9 in-person events (with refreshments!) this Spring Quarter. Please join us in learning more about current technologies and opportunities in the biotechnology and medical device industries. We hope to see you there!
Come check out my poster next week at BioPhys in SF! Still lots of work to go, but I'm excited to have made some progress!
Dr. Jennifer Davis, @AbbyNagle, and Dr. @MichaelRegnier9 at @UWBioE engineered a new #iPSC line in which the FRET tension sensor was knocked into the endogenous vinculin locus, which permitted consistent native levels of vinculin expression. 🧫
Read more: bit.ly/3uQdYe3
Abby Nagle retweeted
sciencedirect.com/science/ar…
So excited about our new study on fibroblast plasticity and its role in cardiac repair in @CellStemCell It was a spectacular team effort by @DNBugg, @lrjbailey, @BellaReichardt ,@Kalen_Z_Robeson, & @coledeforest!
Abby Nagle retweeted
Our local blood supply has hit emergency levels. We're asking everyone who is feeling healthy - especially O negative and O positive donors - to please schedule a donation ASAP and in the next three weeks. Schedule your donation today at schedule.bloodworksnw.org or 800-398-7888
Abby Nagle retweeted
We're hiring! The Center for Cardiovascular Biology, housed in our dept., invites applications from qualified candidates for a faculty position at the rank of Asst. Prof. whose research program is in the field of #CardiacBiology.
Details: apply.interfolio.com/100717
@biologistbill
ALT White background and purple font with the job title, Interfolio link, and department logo.
Abby Nagle retweeted
Join BioEngage and the Bioengineering Justice, Equity, Diversity and Inclusion Committee in our "DEI in Biotech Virtual Industry Panel" on Feb 23, 2021 at 11:30 AM-12:30 PM PST!
Please RSVP with this link: forms.gle/SooYnNr9Vjg7FxPc8
(open to UW-affiliated personnel only)
Abby Nagle retweeted
Being restricted from lab was a good reason to finally get this written! Check out our latest preprint on how MBNL1 regulates cardiac fibroblast cell state! biorxiv.org/content/10.1101/…
Happy new year! Especially to those who decided not to travel this time and are spending the holiday alone 🎉 See y’all in 2021!
Abby Nagle retweeted
Thrilled about our new review on the regulation of cardiac fibroblast cell state just published in Cell Signaling. So proud of @BellaReichardt, @Kalen_Z_Robeson, and @MichaelRegnier9 for a great team effort! Read it here: authors.elsevier.com/a/1cHZf…
Abby Nagle retweeted
Bugg & colleagues demonstrate that aligned #collagen in #MyocardialInfarction induces #p38, #YAP, & #TEAD interactions & these signals are required for #cardiac #fibroblast to #myofibroblast transitions. ow.ly/IUOd30rgY7s
@rossbreth @kellystevenslab @JD98119
Excited to see this published! Congrats @ElphegeNoraLab and @benoitbruneau, and thank you both for the training! 👩🔬
Our latest, on CTCF binding polarity and genome folding. Led by @ElphegeNoraLab and featuring @LCaccianini, @gfudenberg, Kevin So, Vasu Kameswaran, @abbynagle, @awuebersohn and many others @GladstoneInst and @institut_curie nature.com/articles/s41467-0…
Abby Nagle retweeted
Our updated manuscript on the role of the CTCF N-terminus in 3D genome folding is out today in @NatureComms 📰nature.com/articles/s41467-0…
Initial findings summarized here 👉xitter.cf/ElphegeNoraLab/status/…
For our new observations scroll down 👇
1/7 In this new preprint we investigated how CTCF controls genome folding.
TLDR: it’s about the CTCF N-terminus.
biorxiv.org/cgi/content/shor…
Collaborative work between lab of @benoitbruneau, @LCaccianini (Maxime Dahan lab), @gfudenberg (Katherine Pollard lab)
Abby Nagle retweeted
“My wish is that this will provide a positive message to the young girls who would like to follow the path of science, and to show them that women in science can also have an impact through the research that they are performing.”
- 2020 Chemistry Laureate Emmanuelle Charpentier.
Amazing news!! What a great day for women in science. Jennifer Doudna is a role model of mine for her brilliance and insight, as well as for being just a good human. Also, go bears! 🏅💙
Jennifer Doudna wins 2020 Nobel Prize in Chemistry!
The groundbreaking power & versatility of CRISPR-Cas9 has opened up new & wide-ranging possibilities across biology, agriculture & medicine, including the treatment of thousands of intractable diseases. news.berkeley.edu/2020/10/07…
